1. Home
  2. RDY vs DRH Comparison

RDY vs DRH Comparison

Compare RDY & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • DRH
  • Stock Information
  • Founded
  • RDY 1984
  • DRH 2004
  • Country
  • RDY India
  • DRH United States
  • Employees
  • RDY N/A
  • DRH N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • DRH Real Estate Investment Trusts
  • Sector
  • RDY Health Care
  • DRH Real Estate
  • Exchange
  • RDY Nasdaq
  • DRH Nasdaq
  • Market Cap
  • RDY 2.1B
  • DRH 1.7B
  • IPO Year
  • RDY N/A
  • DRH 2005
  • Fundamental
  • Price
  • RDY $13.24
  • DRH $7.22
  • Analyst Decision
  • RDY Buy
  • DRH Hold
  • Analyst Count
  • RDY 1
  • DRH 5
  • Target Price
  • RDY $17.00
  • DRH $10.05
  • AVG Volume (30 Days)
  • RDY 1.9M
  • DRH 2.7M
  • Earning Date
  • RDY 05-06-2025
  • DRH 05-01-2025
  • Dividend Yield
  • RDY 3.61%
  • DRH 5.11%
  • EPS Growth
  • RDY 2.68
  • DRH N/A
  • EPS
  • RDY 0.75
  • DRH 0.18
  • Revenue
  • RDY $3,637,607,642.00
  • DRH $1,129,883,000.00
  • Revenue This Year
  • RDY $17.23
  • DRH $2.40
  • Revenue Next Year
  • RDY $9.19
  • DRH $2.94
  • P/E Ratio
  • RDY $17.94
  • DRH $40.19
  • Revenue Growth
  • RDY 14.74
  • DRH 5.12
  • 52 Week Low
  • RDY $12.50
  • DRH $7.07
  • 52 Week High
  • RDY $16.89
  • DRH $10.00
  • Technical
  • Relative Strength Index (RSI)
  • RDY 48.34
  • DRH 30.02
  • Support Level
  • RDY $13.09
  • DRH $7.54
  • Resistance Level
  • RDY $13.85
  • DRH $7.90
  • Average True Range (ATR)
  • RDY 0.14
  • DRH 0.21
  • MACD
  • RDY 0.02
  • DRH -0.02
  • Stochastic Oscillator
  • RDY 19.74
  • DRH 14.56

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.

Share on Social Networks: